Employing uteroplacental tissue at Day 35 of gestation, we determined the n
ucleic acid sequence of canine preprorelaxin using reverse transcription- a
nd rapid amplification of cDNA ends-polymerase chain reaction. Canine prepr
orelaxin cDNA consisted of 534 base pairs encoding a protein of 177 amino a
cids with a signal peptide of 25 amino acids (aa), a B domain of 35 aa, a C
domain of 93 aa, and an A domain of 24 aa. The putative receptor binding r
egion in the N'-terminal part of the canine relaxin B domain GRDYVR contain
ed two substitutions from the classical motif (E-->D and L-->Y). Canine pre
prorelaxin shared highest homology with porcine and equine preprorelaxin. N
orthern analysis revealed a l-kilobase transcript present in total RNA of c
anine uteroplacental tissue but not of kidney tissue. Uteroplacental tissue
from two bitches each at Days 30 and 35 of gestation were studied by in si
tu hybridization to localize relaxin mRNA. Immunohistochemistry for relaxin
, cytokeratin, vimentin, and von Willebrand factor was performed on uteropl
acental tissue at Day 30 of gestation. The basal cell layer at the core of
the chorionic villi was devoid of relaxin mRNA and immunoreactive relaxin o
r vimentin but was immunopositive for cytokeratin and identified as cytotro
phoblast cells. The cell layer surrounding the chorionic villi displayed sp
ecific hybridization signals for relaxin mRNA and immunoreactivity for rela
xin and cytokeratin but not for vimentin, and was identified as syncytiotro
phoblast. Those areas of the chorioallantoic tissue with most intense relax
in immunoreactivity were highly vascularized as demonstrated by immunoreact
ive von Willebrand factor expressed on vascular endothelium. The uterine gl
ands and non-placental uterine areas of the canine zonary girdle placenta w
ere devoid of relaxin mRNA and relaxin. We conclude that the syncytiotropho
blast is the source of relaxin in the canine placenta.